Antidepressant interactions with warfarin

被引:29
作者
Duncan, D
Sayal, K
McConnell, H
Taylor, D
机构
[1] Bethlem & Maudsley NHS Trust, London SE5 8AZ, England
[2] Univ London Kings Coll Hosp, Inst Psychiat, London, England
关键词
antidepressants; cytochrome p450; interaction; warfarin;
D O I
10.1097/00004850-199803000-00006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interactions between warfarin and antidepressants can have potentially serious consequences resulting from enhanced or reduced anticoagulant activity. Information about such interactions was obtained from a Medline and hand search of the published literature, and by directly contacting manufacturers. The different classes of antidepressants are discussed in turn. The possible mechanisms are considered with particular reference to the cytochrome p450 system. From currently available data on the newer antidepressants our conclusions are that citalopram, nefazodone and sertraline may be relatively less likely to interact with warfarin. Fluoxetine, fluvoxamine, paroxetine and moclobemide appear to have the highest potential of the antidepressants for interactions. There is insufficient data on venlafaxine to make a prediction. The clinical implications of these findings are discussed and specific recommendations for International Normalized Ratio monitoring are suggested. (C) 1998 Rapid Science Ltd.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 42 条
[1]   Pharmacokinetics, metabolism and interactions of acid pump inhibitors - Focus on omeprazole, lansoprazole and pantoprazole [J].
Andersson, T .
CLINICAL PHARMACOKINETICS, 1996, 31 (01) :9-28
[2]   Effect of sertraline on protein binding of warfarin [J].
Apseloff, G ;
Wilner, KD ;
Gerber, N ;
Tremaine, LM .
CLINICAL PHARMACOKINETICS, 1997, 32 (Suppl 1) :37-42
[3]  
Askinazi C, 1996, AM J PSYCHIAT, V153, P135
[4]  
BANNISTER SJ, 1989, ACTA PSYCHIAT S S350, V80, P95
[5]  
BEELEY L, 1988, B W MIDLANDS CTR ADV, V26, P21
[6]   FLUVOXAMINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN DEPRESSIVE-ILLNESS [J].
BENFIELD, P ;
WARD, A .
DRUGS, 1986, 32 (04) :313-334
[7]   FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J].
BROSEN, K ;
SKJELBO, E ;
RASMUSSEN, BB ;
POULSEN, HE ;
LOFT, S .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1211-1214
[8]  
BROSEN K, 1996, SELECTIVE SEROTONIN, P87
[9]  
CIRAULO DA, 1990, J CLIN PSYCHOPHARM, V10, P213
[10]  
CLAIRE RJ, 1991, AM J PSYCHIAT, V148, P1604